TNF Pharmaceuticals (TNFA) Competitors $3.89 -0.15 (-3.71%) Closing price 04:00 PM EasternExtended Trading$3.97 +0.08 (+2.06%) As of 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock TNFA vs. ARWR, SRRK, TLX, VKTX, XENE, AMRX, CRNX, RARE, KYMR, and MORShould you be buying TNF Pharmaceuticals stock or one of its competitors? The main competitors of TNF Pharmaceuticals include Arrowhead Pharmaceuticals (ARWR), Scholar Rock (SRRK), Telix Pharmaceuticals (TLX), Viking Therapeutics (VKTX), Xenon Pharmaceuticals (XENE), Amneal Pharmaceuticals (AMRX), Crinetics Pharmaceuticals (CRNX), Ultragenyx Pharmaceutical (RARE), Kymera Therapeutics (KYMR), and MorphoSys (MOR). These companies are all part of the "pharmaceutical products" industry. TNF Pharmaceuticals vs. Its Competitors Arrowhead Pharmaceuticals Scholar Rock Telix Pharmaceuticals Viking Therapeutics Xenon Pharmaceuticals Amneal Pharmaceuticals Crinetics Pharmaceuticals Ultragenyx Pharmaceutical Kymera Therapeutics MorphoSys Arrowhead Pharmaceuticals (NASDAQ:ARWR) and TNF Pharmaceuticals (NASDAQ:TNFA) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk, dividends and media sentiment. Is ARWR or TNFA more profitable? Arrowhead Pharmaceuticals' return on equity of -40.91% beat TNF Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Arrowhead PharmaceuticalsN/A -40.91% -11.62% TNF Pharmaceuticals N/A -69.21%-33.98% Which has higher earnings & valuation, ARWR or TNFA? TNF Pharmaceuticals has lower revenue, but higher earnings than Arrowhead Pharmaceuticals. Arrowhead Pharmaceuticals is trading at a lower price-to-earnings ratio than TNF Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArrowhead Pharmaceuticals$3.55M1,157.49-$599.49M-$1.28-23.22TNF PharmaceuticalsN/AN/A-$23.36M-$231.00-0.02 Which has more volatility & risk, ARWR or TNFA? Arrowhead Pharmaceuticals has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500.Comparatively, TNF Pharmaceuticals has a beta of 2.04, meaning that its stock price is 104% more volatile than the S&P 500. Does the media favor ARWR or TNFA? In the previous week, Arrowhead Pharmaceuticals had 15 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 17 mentions for Arrowhead Pharmaceuticals and 2 mentions for TNF Pharmaceuticals. TNF Pharmaceuticals' average media sentiment score of 1.11 beat Arrowhead Pharmaceuticals' score of 0.57 indicating that TNF Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Arrowhead Pharmaceuticals 6 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive TNF Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders believe in ARWR or TNFA? 62.6% of Arrowhead Pharmaceuticals shares are held by institutional investors. Comparatively, 9.6% of TNF Pharmaceuticals shares are held by institutional investors. 4.3% of Arrowhead Pharmaceuticals shares are held by insiders. Comparatively, 0.5% of TNF Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts prefer ARWR or TNFA? Arrowhead Pharmaceuticals currently has a consensus target price of $43.14, indicating a potential upside of 45.16%. Given Arrowhead Pharmaceuticals' stronger consensus rating and higher probable upside, equities analysts plainly believe Arrowhead Pharmaceuticals is more favorable than TNF Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Arrowhead Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 3.00TNF Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryArrowhead Pharmaceuticals beats TNF Pharmaceuticals on 11 of the 15 factors compared between the two stocks. Get TNF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNFA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TNFA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNFA vs. The Competition Export to ExcelMetricTNF PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.95M$2.84B$5.79B$10.15BDividend YieldN/A56.65%5.69%4.61%P/E Ratio-0.0223.5374.5925.92Price / SalesN/A534.82454.0285.55Price / CashN/A169.2537.0859.91Price / Book0.015.3712.156.29Net Income-$23.36M$32.95M$3.28B$270.85M7 Day Performance17.88%1.31%0.98%3.35%1 Month Performance-64.64%8.31%7.20%6.40%1 Year Performance-97.36%0.29%63.06%28.21% TNF Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNFATNF Pharmaceuticals0.7102 of 5 stars$3.89-3.7%N/A-97.3%$6.95MN/A-0.026Positive NewsGap DownARWRArrowhead Pharmaceuticals4.1472 of 5 stars$23.26+5.6%$43.14+85.5%+41.9%$3.24B$3.55M-18.33400Analyst RevisionSRRKScholar Rock4.4877 of 5 stars$33.19+1.7%$45.75+37.8%+266.4%$3.19B$33.19M-11.39140News CoveragePositive NewsTLXTelix Pharmaceuticals3.6552 of 5 stars$9.35-2.1%$22.33+139.0%N/A$3.17B$637.77M0.00N/AAnalyst ForecastVKTXViking Therapeutics4.2831 of 5 stars$26.83-0.8%$86.92+224.0%-57.7%$3.04BN/A-17.6620Positive NewsXENEXenon Pharmaceuticals2.3736 of 5 stars$38.96+0.6%$53.20+36.5%-3.7%$3.02B$9.43M-11.02210Positive NewsAMRXAmneal Pharmaceuticals2.9377 of 5 stars$9.45-1.2%$11.60+22.8%+20.7%$2.99B$2.79B954.058,100Positive NewsCRNXCrinetics Pharmaceuticals3.6943 of 5 stars$31.72+2.4%$68.86+117.1%-33.5%$2.99B$1.04M-7.72210Positive NewsRAREUltragenyx Pharmaceutical4.4719 of 5 stars$30.70+2.5%$81.50+165.5%-44.6%$2.97B$560.23M-5.581,294Positive NewsAnalyst ForecastKYMRKymera Therapeutics2.6662 of 5 stars$41.12-0.2%$58.76+42.9%+3.2%$2.96B$47.07M-11.93170Positive NewsMORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730 Related Companies and Tools Related Companies Arrowhead Pharmaceuticals Alternatives Scholar Rock Alternatives Telix Pharmaceuticals Alternatives Viking Therapeutics Alternatives Xenon Pharmaceuticals Alternatives Amneal Pharmaceuticals Alternatives Crinetics Pharmaceuticals Alternatives Ultragenyx Pharmaceutical Alternatives Kymera Therapeutics Alternatives MorphoSys Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNFA) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored6-Figure Target for BTC by 2025Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredWall Street laughed at Trump’s “Smart Dollar.” Now they’re all in."THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TNF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TNF Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TNFA Stock Alerts